This compound is a pharmaceutical intermediate featuring a benzimidazole core linked to a difluorinated chromane ring via an ether bridge. It is primarily used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
7-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-N,2-dimethyl-3H-benzimidazole-5-carboxamide
research compound
Tegoprazan
pharmaceutical raw material
(4R)-Tegoprazan
pharmaceutical raw material
B-(5-Chloro-6-methoxy-3-pyridinyl)boronic acid
pharmaceutical intermediate
2-Cyano-6-methoxybenzothiazole
pharmaceutical intermediate
L-homophenylalanine
pharmaceutical intermediate
(Azetidin-3-yl)(methyl)carbamic acid tert-butyl ester hydrochloride
pharmaceutical intermediate
7-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-2-methyl-3H-benzimidazole-5-carboxylic acid
ISYSUUMRBSNENL-UHFFFAOYSA-N
CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.